A phase I study of a yeast-based therapeutic cancer vaccine, GI-6301, targeting brachyury in patients with metastatic carcinoma.
Harpreet Singh
No relevant relationships to disclose
Christopher Ryan Heery
No relevant relationships to disclose
Jennifer L. Marte
No relevant relationships to disclose
Benedetto Farsaci
No relevant relationships to disclose
Ravi Amrit Madan
No relevant relationships to disclose
Geraldine Helen O'Sullivan Coyne
No relevant relationships to disclose
Claudia Palena
No relevant relationships to disclose
Timothy C. Rodell
Employment or Leadership Position - GlobeImmune
Stock Ownership - GlobeImmune
Research Funding - GlobeImmune
Jeffrey Schlom
Research Funding - GlobeImmune
James L. Gulley
No relevant relationships to disclose